Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts

MLA

Jing Li, et al. “Phase I Trial of a Humanized, Fc Receptor Nonbinding Anti-CD3 Antibody, Hu12F6mu in Patients Receiving Renal Allografts.” MAbs, vol. 2, July 2010, pp. 449–56. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5c23242a2e67798afdcbb345453d167c&authtype=sso&custid=ns315887.

APA

Jing Li, Bo Zhou, Weizhu Qian, Hao Wang, Xu Zhang, Yajun Guo, Dapeng Zhang, Sheng Hou, Jianxin Dai, Jianghua Chen, Min Tan, Bohua Li, Jian-zhong Shentu, & Li Du. (2010). Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts. MAbs, 2, 449–456.

Chicago

Jing Li, Bo Zhou, Weizhu Qian, Hao Wang, Xu Zhang, Yajun Guo, Dapeng Zhang, et al. 2010. “Phase I Trial of a Humanized, Fc Receptor Nonbinding Anti-CD3 Antibody, Hu12F6mu in Patients Receiving Renal Allografts.” MAbs 2 (July): 449–56. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5c23242a2e67798afdcbb345453d167c&authtype=sso&custid=ns315887.